Biogen Adds Drug with Narrow Approval to 340B Contract Pharmacy Restrictions
Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...]
*Sign up for news summaries and alerts from 340B Report